Making the Case for Medically Integrated Dispensing
OncLive, Barry Fortner, PhD |
Today, 35% of oncology drugs in the pipeline are oral, according to a recent report by the Community Oncology Alliance (COA). With the rise of oral oncolytic prescribing and development, more oncology practices are implementing in-office dispensing programs to provide a seamless treatment experience for patients. The terminology for this practice is now commonly referred to as medically integrated dispensing, which more accurately reflects the level of clinically coordinated care that patients can expect from their community physicians.
For the full article, visit OncLive.